hCT(18-32)

hCT (18-32), a subsynthetic derivative originating from human calcitonin (hCT), represents a paramount peptide indispensably serving as an avid agonist, interacting strategically with calcitonin receptors. This irreplaceable agent maintains a broad scope of applicability within the realm of biomedical research, predominantly employed to delve deeper into the intricate intricacies of bone metabolism. Its pivotal role in comprehensively examining the treatment paradigms of osteoporosis alongside Paget's disease, two intricately woven bone-related afflictions, renders hCT (18-32) an invaluable asset.

Online Inquiry